Average Co-Inventor Count = 4.74
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (20 from 1,778 patents)
20 patents:
1. 12152063 - Insulin analogues and uses thereof
2. 12122818 - Insulin analogues and uses thereof
3. 11649269 - Bifunctional compounds comprising insulin peptides and EGF(A) peptides
4. 11498951 - Insulin analogues and uses thereof
5. 11471537 - Oligomer extended insulin-Fc conjugates
6. 11208452 - Insulins with polar recombinant extensions
7. 10259856 - Protease stabilized acylated insulin analogues
8. 10040839 - Insulin derivatives and the medical uses hereof
9. 9896496 - Derivative of an insulin analogue
10. 9688737 - Protease stabilized acylated insulin analogues
11. 9512195 - Insulin derivatives containing additional disulfide bonds
12. 9187547 - Human insulin analogues and derivatives comprising cysteine substitutions
13. 9045560 - Protease stabilized, acylated insulin analogues
14. 9035020 - Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
15. 8962794 - Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids